Finally, we will use western blotting to evaluate the levels of NUF2 in NSCLC and adjacent tissues to verify that NUF2 can indeed be used as a target for in-depth research on NSCLC treatment. The gene discussed is NUF2; the disease is non-small cell lung carcinoma.